XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2018   10,862,651    
Beginning balance at Dec. 31, 2018 $ 191,542 $ 62,855 $ 132,460 $ (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 12,551   12,551  
Net unrealized gain on securities available for sale, net of tax 7,801     7,801
Net unrealized loss on cash flow hedging derivative instruments, net of tax (1,363)     (1,363)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7     7
Comprehensive income (loss) 18,996   12,551 6,445
Cash dividends declared (6,424)   (6,424)  
Equity compensation expense 244 $ 244    
Payment to repurchase common stock (in shares)   (4,104)    
Payment to repurchase common stock (94)   (94)  
Issuance of restricted stock (in shares)   19,087    
Proceeds from sale of common stock (in shares)   12,602    
Proceeds from sale of common stock $ 329 $ 329    
Ending balance (in shares) at Jun. 30, 2019 10,890,236 10,890,236    
Ending balance at Jun. 30, 2019 $ 204,593 $ 63,428 138,493 2,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends declared (usd per share) $ 0.59      
     Net income $ 6,395      
Net unrealized gain on securities available for sale, net of tax 4,289      
Net unrealized loss on cash flow hedging derivative instruments, net of tax (898)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 4      
Ending balance (in shares) at Jun. 30, 2019 10,890,236 10,890,236    
Ending balance at Jun. 30, 2019 $ 204,593 $ 63,428 138,493 2,672
Beginning balance (in shares) at Dec. 31, 2019 10,899,210 10,899,210    
Beginning balance at Dec. 31, 2019 $ 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 13,064   13,064  
Net unrealized gain on securities available for sale, net of tax 3,443     3,443
Net unrealized loss on cash flow hedging derivative instruments, net of tax (6,284)     (6,284)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 36     36
Comprehensive income (loss) 10,259   13,064 (2,805)
Cash dividends declared (6,666)   (6,666)  
Equity compensation expense 312 $ 312    
Payment to repurchase common stock (in shares)   (5,297)    
Payment to repurchase common stock (154)   (154)  
Issuance of restricted stock (in shares)   25,845    
Proceeds from sale of common stock (in shares)   13,670    
Proceeds from sale of common stock $ 325 $ 325    
Ending balance (in shares) at Jun. 30, 2020 10,933,428 10,933,428    
Ending balance at Jun. 30, 2020 $ 216,584 $ 64,710 151,083 791
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends declared (usd per share) $ 0.61      
     Net income $ 6,569      
Net unrealized gain on securities available for sale, net of tax (790)      
Net unrealized loss on cash flow hedging derivative instruments, net of tax (1,414)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 28      
Ending balance (in shares) at Jun. 30, 2020 10,933,428 10,933,428    
Ending balance at Jun. 30, 2020 $ 216,584 $ 64,710 $ 151,083 $ 791